AAAAAA
Results: 1-25/118
Authors:
SARBIA M
STABL M
ZURHAUSEN A
ZIMMERMANN K
WANG LH
FINK U
HEEP H
DUTKOWSKI P
WILLERS R
MULLER W
SEEBER S
GABBERT HE
Citation: M. Sarbia et al., EXPRESSION OF P21(WAF1) PREDICTS OUTCOME OF ESOPHAGEAL CANCER-PATIENTS TREATED BY SURGERY ALONE OR BY COMBINED THERAPY MODALITIES, Clinical cancer research, 4(11), 1998, pp. 2615-2623
Authors:
KORFEL A
SCHEULEN ME
SCHMOLL HJ
GRUNDEL O
HARSTRICK A
KNOCHE M
FELS LM
SKORZEC M
BACH F
BAUMGART J
SASS G
SEEBER S
THIEL E
BERDEL WE
Citation: A. Korfel et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TITANOCENE DICHLORIDE IN ADULTS WITH ADVANCED SOLID TUMORS, Clinical cancer research, 4(11), 1998, pp. 2701-2708
Authors:
STRUMBERG D
ERHARD J
HARSTRICK A
KLAASSEN U
MULLER C
EBERHARDT W
WILKE H
SEEBER S
Citation: D. Strumberg et al., PHASE-I STUDY OF A WEEKLY 1 H INFUSION OF PACLITAXEL IN PATIENTS WITHUNRESECTABLE HEPATOCELLULAR-CARCINOMA, European journal of cancer, 34(8), 1998, pp. 1290-1292
Authors:
HARSTRICK A
GONZALES A
SCHLEUCHER N
VANHOEFER U
LU K
FORMENTO JL
MILANO G
WILKE H
SEEBER S
RUSTUM Y
Citation: A. Harstrick et al., COMPARISON BETWEEN SHORT OR LONG EXPOSURE TO 5-FLUOROURACIL IN HUMAN GASTRIC AND COLON-CANCER CELL-LINES - BIOCHEMICAL-MECHANISM OF RESISTANCE, Anti-cancer drugs, 9(7), 1998, pp. 625-634
Authors:
HARTMANN JT
HARSTRICK A
DAIKELER T
KOLLMANNSBERGER C
MULLER C
SEEBER S
KANZ L
BOKEMEYER C
Citation: Jt. Hartmann et al., PHASE-II STUDY OF CONTINUOUS 120 H INFUSION OF MITOMYCIN-C AS SALVAGECHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER, Anti-cancer drugs, 9(5), 1998, pp. 427-431
Authors:
KLAASSEN U
HARSTRICK A
STRUMBERG D
WILKE H
SEEBER S
Citation: U. Klaassen et al., PACLITAXEL PLUS IFOSFAMIDE IN ADVANCED OVARIAN-CANCER - RESULTS OF A PHASE-I STUDY, Anti-cancer drugs, 9(4), 1998, pp. 359-361
Authors:
KLAASSEN U
WILKE H
WEYHOFEN R
HARSTRICK A
EBERHARDT W
MULLER C
KORN M
HANSKE M
DIERGARTEN K
SEEBER S
Citation: U. Klaassen et al., PHASE-II STUDY WITH CISPLATIN AND PACLITAXEL IN COMBINATION WITH WEEKLY HIGH-DOSE 24 H INFUSIONAL 5-FLUOROURACIL LEUCOVORIN FOR FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER/, Anti-cancer drugs, 9(3), 1998, pp. 203-207
Authors:
KASIMIRBAUER S
KLAASSEN U
KADING J
SEEBER S
Citation: S. Kasimirbauer et al., DETECTION OF ISOLATED BREAST-CARCINOMA CELLS IN BONE-MARROW AND STEM-CELL GRAFTS BY IMMUNOMAGNETIC SEPARATION AND IMMUNOCYTOCHEMISTRY, Annals of oncology, 9, 1998, pp. 103-103
Authors:
BORQUEZ D
RAAB G
HARSTRICK A
WILKE HJ
ACHTERRATH W
EIERMANN W
SEEBER S
Citation: D. Borquez et al., PHASE-I STUDY OF DOCETAXEL (D) IN COMBINATION WITH EPIRUBICIN (E) AS FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 137-137
Authors:
HARSTRICK A
MAYER S
HILGER R
MULLER C
DOHMEN D
KLOPPEL R
VANHOEFER U
SCHEULEN ME
WILKE H
SEEBER S
Citation: A. Harstrick et al., COMBINATION THERAPY WITH INFUSIONAL 5-FU AND TOMUDEX FOR PATIENTS (PTS) WITH ADVANCED COLORECTAL-CANCER - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 170-170
Authors:
WILKE H
VANHOEFER U
HARSTRICK A
ACHTERRATH W
PREUSSER P
CLEMENS MR
THIEL E
FLASSHOVE M
FINK U
SEEBER S
Citation: H. Wilke et al., PHASE-II STUDY OF DOCETAXEL (D) AS SALVAGE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC-CANCER, Annals of oncology, 9, 1998, pp. 246-246
Authors:
NOWROUSIAN MR
WELT A
FOSSA A
KASPER C
SCHRODER J
KUHLMANN S
SCHUTTE J
KLOKE O
STUSCHKE M
SCHULEHEIN K
METZ KA
LEDER LD
SACK H
SEEBER S
Citation: Mr. Nowrousian et al., RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/, Annals of oncology, 9, 1998, pp. 514-514
Authors:
VANHOEFER U
HAPKE G
HARSTRICK A
ACHTERRATH W
RUSTUM YM
SEEBER S
Citation: U. Vanhoefer et al., SCHEDULE-DEPENDENT ANTITUMOR EFFICACY OF IRINOTECAN (CPT-11) AND 5-FLUOROURACIL (5-FU) IN NUDE-MICE BEARING COLON-TUMOR XENOGRAFTS THAT ARERESISTANT TO 5-FU, Annals of oncology, 9, 1998, pp. 634-634
Authors:
MAYER S
HARSTRICK A
MULLER C
DOHMEN D
HILGER R
SCHEULEN ME
WILKE H
SEEBER S
Citation: S. Mayer et al., PHASE-I STUDY OF TOMUDEX COMBINED WITH PROTRACTED INFUSION OF 5-FU INPATIENTS (PTS) WITH METASTATIC COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 633-633
Authors:
WELT A
FOSSA A
BLATTER J
BUKSMAUI S
SEEBER S
NOWROUSIAN MR
Citation: A. Welt et al., GEMCITABINE AS SINGLE-AGENT IN THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN-LYMPHOMA (NHL), Annals of oncology, 9, 1998, pp. 643-643
Authors:
KLAASSEN U
WILKE H
HARSTRICK A
PARI CP
STRUMBERG D
NEWMANN K
EBERHARDT W
ACHTERRATH W
LENAZ L
SEEBER S
Citation: U. Klaassen et al., PACLITAXEL IN COMBINATION WITH WEEKLY 24-HOUR INFUSIONAL 5-FLUOROURACIL PLUS LEUCOVORIN IN THE 2ND-LINE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PHASE-II STUDY, Annals of oncology, 9(1), 1998, pp. 45-50
Authors:
KLAASSEN U
WILKE H
HARSTRICK A
SEEBER S
Citation: U. Klaassen et al., FLUOROURACIL-BASED COMBINATIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER, Oncology, 12(1), 1998, pp. 31-35
Authors:
FOSSA A
MUER M
KASPER C
WELT A
SEEBER S
NOWROUSIAN MR
Citation: A. Fossa et al., BOLUS VINCRISTINE AND EPIRUBICIN WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE (VECD) AS INDUCTION AND SALVAGE TREATMENT IN MULTIPLE-MYELOMA, Leukemia, 12(3), 1998, pp. 422-426
Authors:
EBERHARDT W
WILKE H
STAMATIS G
STUSCHKE M
HARSTRICK A
MENKER H
KRAUSE B
MUELLER MR
STAHL M
FLASSHOVE M
BUDACH V
GRESCHUCHNA D
KONIETZKO N
SACK H
SEEBER S
Citation: W. Eberhardt et al., PREOPERATIVE CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION THERAPY BASED ON HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND DEFINITIVE SURGERY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF A PHASE-II TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 622-634
Authors:
KASIMIRBAUER S
OTTINGER HD
BELKA C
STELLBERG W
HALFMEYER K
GEWALTIG I
HARSTRICK A
GROSSEWILDE H
SEEBER S
SCHEULEN ME
Citation: S. Kasimirbauer et al., ANALYSIS OF THE RELATIONSHIP OF P53 STATUS AND RESISTANCE TO CHEMOTHERAPY IN CANCER CELL-LINES AS EVALUATED BY LUMINOMETRIC IMMUNOASSAY (LIA), Tumordiagnostik & Therapie, 19(4), 1998, pp. 113-118
Authors:
HARSTRICK A
VANHOEFER U
SEEBER S
Citation: A. Harstrick et al., NEW DRUGS IN COLORECTAL-CANCER - A REVIEW OF ANTITUMOR-ACTIVITY AND CROSS-RESISTANCE PATTERNS OF TOPOISOMERASE-I INHIBITORS, THYMIDYLATE SYNTHETASE INHIBITORS, AND OXALIPLATIN, Onkologie, 21(2), 1998, pp. 95-103
Authors:
VANHOEFER U
HARSTRICK A
SEEBER S
Citation: U. Vanhoefer et al., EFFECT OF 4-HYDROPEROXYIFOSFAMIDE ON THE CELLULAR GLUTATHIONE PATHWAY, Onkologie, 21, 1998, pp. 5-9
Authors:
HILGER RA
HARSTRICK A
EBERHARDT W
OBERHOFF C
SKORZEC M
BAUMGART J
SEEBER S
SCHEULEN ME
Citation: Ra. Hilger et al., CLINICAL PHARMACOKINETICS OF INTRAVENOUS TREOSULFAN IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 42(2), 1998, pp. 99-104
Authors:
KIRCH HC
SCHRODER J
HOPPE H
ESCHE H
SEEBER S
SCHUTTE J
Citation: Hc. Kirch et al., RECOMBINANT GENE-PRODUCTS OF 2 NATURAL VARIANTS OF THE HUMAN CYTIDINEDEAMINASE GENE CONFER DIFFERENT DEAMINATION RATES OF CYTARABINE IN-VITRO, Experimental hematology, 26(5), 1998, pp. 421-425
Authors:
KASIMIRBAUER S
OTTINGER H
MEUSERS P
BEELEN DW
BRITTINGER G
SEEBER S
SCHEULEN ME
Citation: S. Kasimirbauer et al., IN ACUTE MYELOID-LEUKEMIA, COEXPRESSION OF AT LEAST 2 PROTEINS, INCLUDING P-GLYCOPROTEIN, THE MULTIDRUG RESISTANCE-RELATED PROTEIN, BCL-2, MUTANT P53, AND HEAT-SHOCK-PROTEIN-27, IS PREDICTIVE OF THE RESPONSE TO INDUCTION CHEMOTHERAPY, Experimental hematology, 26(12), 1998, pp. 1111-1117